ReviewCancers2020

MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.

Annelisa M Cornel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.